Compare RMNI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMNI | SMTI |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.7M | 322.2M |
| IPO Year | 2015 | 2008 |
| Metric | RMNI | SMTI |
|---|---|---|
| Price | $4.83 | $32.72 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | $7.17 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 553.5K | 59.0K |
| Earning Date | 10-29-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 197.50 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $431,496,000.00 | $15,586,976.00 |
| Revenue This Year | $5.92 | $11.81 |
| Revenue Next Year | $5.90 | $12.75 |
| P/E Ratio | $47.73 | ★ N/A |
| Revenue Growth | 5.33 | ★ 32.47 |
| 52 Week Low | $2.87 | $16.05 |
| 52 Week High | $5.68 | $35.52 |
| Indicator | RMNI | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 47.34 |
| Support Level | $4.02 | $30.40 |
| Resistance Level | $5.01 | $34.90 |
| Average True Range (ATR) | 0.29 | 0.98 |
| MACD | -0.04 | 0.15 |
| Stochastic Oscillator | 23.38 | 85.03 |
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. The company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management, database, and technology software systems. Geographically, the company generates its revenue from the United States of America and the International market.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.